Therapy Areas: Cardiovascular
Medtronic confirms separation of MiniMed
16 October 2026 - Healthcare technology company Medtronic plc (NYSE:MDT) announced on Thursday that it has completed its separation of MiniMed Group Inc (Nasdaq:MMED).Medtronic elected to exchange all...
Philips-led EXIT-CVD consortium launches cardiovascular clinical studies across Europe
15 October 2026 - Dutch health technology company Royal Philips (NYSE:PHG) (AEX:PHIA) on Thursday announced the launch of EXIT-CVD, a five-year research initiative led by Philips and University Medica...
FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes
8 October 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug ...
Genentech reports positive Phase II results for enicepatide in type 2 diabetes
22 September 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Tuesday reported positive topline Phase II results for enicepatide, an investigationa...
Otsuka ICU Medical recalls 0.9% Sodium Chloride Injection
18 September 2026 - Otsuka ICU Medical LLC, a manufacturer of IV solutions for healthcare providers, announced on Thursday that it is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Inj...
US FDA grants orphan drug designation for Lundbeck's asedebart
11 September 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B), which focuses on brain health, said on Friday it has received US Food and Drug Administration orphan drug designatio...